Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Nat Prod Rep. 2013 Apr;30(4):546-64. doi: 10.1039/c3np20094a.
Since the advent of high-throughput screening (HTS) in the early 1990s, a wealth of innovative technologies have been proposed and implemented for the effective localization and characterization of bioactive constituents in complex matrices. The latest developments in this field are reviewed under the perspective of their applicability to natural product-based drug discovery. The approaches discussed here include TLC-based bioautography, HPLC-based assays with on-line, at-line and off-line detection, as well as affinity-based methods, such as frontal affinity chromatography, pulsed ultrafiltration mass spectrometry, imprinted polymers, and affinity capillary electrophoresis. Selected practical examples are given to illustrate the strengths and limitations of these approaches in contemporary natural product lead discovery. In addition, compatibility issues of natural product extracts and HTS are addressed, and selected protocols for the generation of high quality libraries are presented.
自 20 世纪 90 年代初高通量筛选 (HTS) 问世以来,已经提出并实施了大量创新技术,以有效定位和表征复杂基质中的生物活性成分。从基于天然产物的药物发现的适用性角度来看,综述了该领域的最新进展。这里讨论的方法包括基于 TLC 的生物自显影、带有在线、在线和离线检测的 HPLC 测定方法,以及基于亲和性的方法,如前沿亲和色谱、脉冲超滤质谱、印迹聚合物和亲和毛细管电泳。选择了一些实际的例子来说明这些方法在当代天然产物先导发现中的优缺点。此外,还解决了天然产物提取物与 HTS 的兼容性问题,并提出了生成高质量文库的一些方案。